Trial intelligence / Profile preview

Volume-reduced versus standard platelet transfusions in neonates

NL-OMON36168Recruiting

Sponsor
Erasmus MC
Start
Mar 2012
Modality
Cell Therapies, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of platelets in Thrombocytopenia (2 arms), sponsored by Erasmus MC. Primary endpoints: Platelet transfusion recovery at 1 hour and Platelet transfusion recovery at 24 hours. Started Mar 2012; status: recruiting.

02

Drugs

platelets
03

Conditions

Thrombocytopenia

Beyond the preview

Go deeper on NL-OMON36168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call